Ontology highlight
ABSTRACT:
SUBMITTER: Rothenstein JM
PROVIDER: S-EPMC6001759 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
Current oncology (Toronto, Ont.) 20180613 Suppl 1
The treatment of advanced non-small-cell lung cancer (nsclc) has undergone a paradigm shift since the early 2000s. The identification of molecular subtypes of the disease, based on oncogenic drivers, has led to the development of personalized medicine and the ability to deliver molecularly targeted therapies to patients. In the 10 years that have elapsed since the discovery of the <i>ALK</i> gene in a patient with nsclc, several active drugs have moved rapidly from bench to bedside, and multiple ...[more]